Grass pollen sublingual immunotherapy tablet 300 IR
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Grass pollen sublingual immunotherapy tablet 300 IR, covering 2016-05-19 to 2016-05-26. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]